249 related articles for article (PubMed ID: 32987398)
1. Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.
Sadasivan C; Chow JTY; Sheng B; Chan DKH; Fan Y; Choi PCL; Wong JKT; Tong MMB; Chan TN; Fung E; Kam KKH; Chan JYS; Chi WK; Paterson DI; Senaratne M; Brass N; Oudit GY; Lee APW
PLoS One; 2020; 15(9):e0239675. PubMed ID: 32987398
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Fabry Disease in patients with left ventricular hypertrophy in Turkey: Multicenter study (LVH-TR subgroup analysis).
Güzel T; Çağlar FNT; Ekici B; Kış M; Öztaş S; Öz A; Gök G; Kolak Z; Akşit E; Sarıca SA; Bayrak M; Birdal O; Uğuz B; Gitmez M; Berk Gİ; Oğuz M; Çalık AN; Kılıç S; Zoghi M; Ergene AO
Int J Cardiovasc Imaging; 2023 Jun; 39(6):1143-1155. PubMed ID: 36920623
[TBL] [Abstract][Full Text] [Related]
4. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation.
Hsu TR; Hung SC; Chang FP; Yu WC; Sung SH; Hsu CL; Dzhagalov I; Yang CF; Chu TH; Lee HJ; Lu YH; Chang SK; Liao HC; Lin HY; Liao TC; Lee PC; Li HY; Yang AH; Ho HC; Chiang CC; Lin CY; Desnick RJ; Niu DM
J Am Coll Cardiol; 2016 Dec; 68(23):2554-2563. PubMed ID: 27931613
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.
Kim WS; Kim HS; Shin J; Park JC; Yoo HW; Takenaka T; Tei C
J Korean Med Sci; 2019 Feb; 34(7):e63. PubMed ID: 30804731
[TBL] [Abstract][Full Text] [Related]
6. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation.
Baptista A; Magalhães P; Leão S; Carvalho S; Mateus P; Moreira I
Arq Bras Cardiol; 2015 Aug; 105(2):139-44. PubMed ID: 26269958
[TBL] [Abstract][Full Text] [Related]
7. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
8. Screening for Fabry disease in patients with left ventricular hypertrophy.
Mawatari K; Yasukawa H; Oba T; Nagata T; Togawa T; Tsukimura T; Kyogoku S; Ohshima H; Minami T; Sugi Y; Sakuraba H; Imaizumi T
Int J Cardiol; 2013 Aug; 167(3):1059-61. PubMed ID: 23168011
[No Abstract] [Full Text] [Related]
9. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS).
Palecek T; Honzikova J; Poupetova H; Vlaskova H; Kuchynka P; Golan L; Magage S; Linhart A
J Inherit Metab Dis; 2014 May; 37(3):455-60. PubMed ID: 24173410
[TBL] [Abstract][Full Text] [Related]
10. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey.
Barman HA; Özcan S; Atıcı A; Özgökçe C; Öztürk A; Kafalı AE; Çakar NE; Tavşanlı ME; Küçük M; Şahin I; Okuyan E
Anatol J Cardiol; 2020 Jan; 23(2):79-85. PubMed ID: 32011328
[TBL] [Abstract][Full Text] [Related]
11. Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A).
Lin HY; Huang CH; Yu HC; Chong KW; Hsu JH; Lee PC; Cheng KH; Chiang CC; Ho HJ; Lin SP; Chen SJ; Lin PK; Niu DM
J Inherit Metab Dis; 2010 Oct; 33(5):619-24. PubMed ID: 20821055
[TBL] [Abstract][Full Text] [Related]
12. A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients.
Kubo T; Amano M; Takashio S; Okumura T; Yamamoto S; Nabeta T; Oikawa M; Kurisu S; Ochi Y; Sugiura K; Baba Y; Kuroiwa H; Hirota T; Yamasaki N; Ishii S; Nochioka K; Takeishi Y; Yasuda S; Tsujita K; Izumi C; Kitaoka H
J Cardiol; 2022 Oct; 80(4):325-331. PubMed ID: 35643740
[TBL] [Abstract][Full Text] [Related]
13. Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations.
Chien YH; Lee NC; Chiang SC; Desnick RJ; Hwu WL
Mol Med; 2012 Jul; 18(1):780-4. PubMed ID: 22437327
[TBL] [Abstract][Full Text] [Related]
14. Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.
Gaggl M; Lajic N; Heinze G; Voigtländer T; Sunder-Plassmann R; Paschke E; Fauler G; Sunder-Plassmann G; Mundigler G
Int J Med Sci; 2016; 13(5):340-6. PubMed ID: 27226774
[TBL] [Abstract][Full Text] [Related]
15. Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
Yamashita S; Saotome M; Satoh H; Kajihara J; Mochizuki Y; Mizuno K; Nobuhara M; Miyajima K; Kumazawa A; Tominaga H; Takase H; Tawarahara K; Wakahara N; Matsunaga M; Wakabayashi Y; Matsumoto Y; Terada H; Sano M; Ohtani H; Urushida T; Hayashi H; Ishii S; Maruyama H; Maekawa Y
Circ J; 2019 Aug; 83(9):1901-1907. PubMed ID: 31308318
[TBL] [Abstract][Full Text] [Related]
16. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance.
Smid BE; van der Tol L; Cecchi F; Elliott PM; Hughes DA; Linthorst GE; Timmermans J; Weidemann F; West ML; Biegstraaten M; Lekanne Deprez RH; Florquin S; Postema PG; Tomberli B; van der Wal AC; van den Bergh Weerman MA; Hollak CE
Int J Cardiol; 2014 Dec; 177(2):400-8. PubMed ID: 25442977
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in Turkish population (LVH-TR).
Kis M; Dogan Y; Yildirim A; Güzel T; Bekar L; Akhan O; Dogdus M; Harbalıoğlu H; Karabulut D; Soydan E; Zoghi M; Ergene O;
Acta Cardiol; 2022 Nov; 77(9):836-845. PubMed ID: 36222672
[TBL] [Abstract][Full Text] [Related]
18. Accuracy diagnosis improvement of Fabry disease from dried blood spots: Enzyme activity, lyso-Gb3 accumulation and GLA gene sequencing.
Delarosa-Rodríguez R; Santotoribio JD; Paula HA; González-Meneses A; García-Morillo S; Jiménez-Arriscado P; Guerrero JM; Macher HC
Clin Genet; 2021 Jun; 99(6):761-771. PubMed ID: 33527381
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.
Chimenti C; Pieroni M; Morgante E; Antuzzi D; Russo A; Russo MA; Maseri A; Frustaci A
Circulation; 2004 Aug; 110(9):1047-53. PubMed ID: 15313943
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
